L-asparaginase

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameL-asparaginase
Drug Alias NameL-ASP左旋门冬酰胺酶L-门冬酰胺酶ASPLeunase +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAspartate-ammonia ligase inhibitorsAmidohydrolases stimulantsAsparagine inhibitors
TargetsAspartate-ammonia ligaseAmidohydrolasesAsparagine
Therapy Area/IndicationsLymphomaPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsLymphomaPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1971/06/25
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesKyowa Hakko Kirin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Hakko Kirin Co Ltd
Inactive CompaniesFudan University
Active IndicationsLymphomaPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeL01XX02
Related LinksN/A